Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind 4-arm study of denosumab and zoledronic acid as adjuvant therapy in cementless total knee arthroplasty
2012-004046-15Phase 2Active
- Sponsor
- Aarhus University Hospital
- Start
- Jul 2013
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of denosumab and zoledronic acid in knee osteoarthritis (OA) (4 arms), sponsored by Aarhus University Hospital. Primary endpoints: Implant migration by RSA and Continuous MTPM. Started Jul 2013; status: active.
02
Drugs
denosumabzoledronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2012-004046-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004046-15.